The 3rd CRISPR MEDiCiNE Conference, April 13-16th, 2026
- CRISPRMED26 Stories from the CMN Community on LinkedIn.
- CRISPRMED26 - Who attended.
- CRISPRMED26 - Meet the Sponsors.
- CRISPRMED26 Abstract Book - View.
CRISPRMED27 - Stay updated
The 3rd CRISPR MEDiCiNE Conference, April 14-16th, 2026 (CRISPRMED26)
CRISPRMED26 - Advancing Medicine for Rare Diseases With Gene Editors
- Meet the global CRISPR Medicine community in Copenhagen, Denmark April 14-16th, 2026.
- The world´s largest CRISPR Medicine Conference including all types of modalities used for the development of the next gene- /cell-based medicine.
- 2 tracks:
- 1) Functional Genomics (screening platforms, target identification, target validation).
- 2) Therapeutics (immunotherapies, new modalities, AI, delivery, safety/off-target, pre-clinical/clinical, standards and regulations).
- Segments: University, Hospital, Biotech, Pharma, CRO, Regulatory, Standards, Legal, Investors, Disease Organisations.
- Scientific conference: 500 delegates, 70 speakers, 150 poster presenters, 2x poster sessions, 35 sponsors, relevant workshops, social and networking events.
- Founders´ Breakfast: Exclusive event for founders, investors and business development teams.
- CRISPRMED26 Satellite Meetings exclusively for CRISPRMED26 attendees:
- EU Regulatory Requirements (CMC, pre-clinical, clinical)
- EU CRISPR Screening and Editing Facilities Forum
- Access, IP Landscape & FTO
- Young researcher events at the conference: Workshops (organised by GHD), Meet & Match, Meet the Experts, WeDoCRISPR Flash Talk...
- Official launch of the European Genomic Medicine Consortium (EGMEDC)
- Opportunity to meet the first CRISPR medicine patients.
- 35 sponsorship packages will be available.
- Organiser: CRISPR Medicine News, CMN.
Supporters: Copenhagen Capacity, Innovation District Copenhagen, Copenhagen Legacy Lab
Check out CRISPRMED24 / CRISPRMED25 for inspiration and CMN LinkedIn for the stories.
Stay updated about next CRISPRMED Event - CRISPRMED27 Newsletter.
CRISPRMED26 Scientific Committee
- Özcan Met, PhD, Ass. Prof. and Head of Cell Therapy Unit and DTU HealthTech, CCIT-DK / DTU, Denmark
- Jakob Nilsson, Prof. and Groupleader (DK Functional Genomics Screening Unit), Danish Cancer Institute, Denmark
- Cecilia Jimenez-Mallebrera, PhD and Research Director, Institut de Recerca Sant Joan de Déu. Hospital Sant Joan de Déu Barcelona and CIBERER, Spain
- Laura Torella, Postdoc, AZ, Sweden
- Alessia Cavazza, Ass. Prof. and Groupleader, Zayed Centre for Research into Rare Diseases in Children, UCL Great Ormond Street Institute of Child Health, University College London, UK























